Autoantibodies (auto-Abs) directed against AT1R acting as agonists or probably positive agonistic modulators inducing pathogenic conditions have been demonstrated several times (22, 91–93) as in women with preeclampsia (21), or in patients with acute vascular graft rejection (19, 94, 95). Here, AGTR1 is linked to preeclampsia.